Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US

JAMA. 2022 Sep 20;328(11):1026-1028. doi: 10.1001/jama.2022.13661.
No abstract available

MeSH terms

  • COVID-19 Vaccines* / therapeutic use
  • COVID-19* / prevention & control
  • Drug Approval
  • Humans
  • Patient Acceptance of Health Care*
  • United States


  • COVID-19 Vaccines
  • NVX-CoV2373 adjuvated lipid nanoparticle